OBJECTIVE: 1) Characterize gene expression using FNA samples taken from follicular lesions to distinguish follicular adenomas from follicular carcinomas, and follicular variant of papillary carcinomas. 2) Be able to utilize fine needle aspirate material to distinguish benign versus malignant follicular thyroid lesions. METHOD: Gene expression analysis of normal thyroid tissue (n ϭ 63) and follicular neoplasms: follicular adenomas (n ϭ 16), follicular thyroid carcinomas (n ϭ 13), follicular variant of papillary carcinoma (n ϭ 24), and papillary thyroid carcinomas (n ϭ 10) was performed taking RNA from core biopsied formalin fixed, paraffin embedded tissues (collected from 1990-2005) and quantified using rt-PCR. In addition, FNA were performed on thyroid nodules (n ϭ 17) in the operating room after thyroid lobectomy (collected from October 2007-Decemeber 2008). Samples were placed in RNA preservative and analyzed for the same markers as in the retrospective series using rt-PCR prior to obtaining final pathology. RESULTS: Quantitative gene analysis detects significantly different levels of trefoil factor-3 expression in follicular adenomas versus follicular carcinomas (p ϭ 0.02). Prospective series final pathology identified chronic thyroiditis (n ϭ 2), nodular hyperplasia (n ϭ 2), multi-nodular goiter (n ϭ 3), FA (n ϭ 2), FC (n ϭ 3), FVPTC (n ϭ 4), HCC (n ϭ 1), and one case where both FA and FVPTC were identified within the same hemi-thyroid sample. RT-PCR of FNA samples identified malignant thyroid nodules to significantly over-express STT3A compared to those with benign disease (pϭ0.046). The combination of STT3A over-expression/Clorf24 under-expression statistically identified malignant disease (pϭ0.03) on FNA samples. CONCLUSION: Gene expression data suggests that there is a difference in expression between STT3A, Clorf24 and TFF3 in follicular adenomas versus carcinomas that may be detected from an FNA sample. These findings must be validated from pre-operative FNAs in larger numbers via a multicenter trail.
Minimally Invasive Video-Assisted Central Neck Dissection
Marci Neidich, MD (presenter); David Steward, MD OBJECTIVE: 1) Learn about safety and effectiveness of elective minimally invasive video-assisted (MIVA) central neck dissection (CND) for thyroid carcinoma. 2) Understand benefits and limitations of this procedure. METHOD: Retrospective study of patients undergoing elective MIVA CND at the time of thyroidectomy during November 2006 to October 2009 was performed. Operations were performed by a single surgeon in an academic center. Primary outcomes included complications and recurrence rates. RESULTS: Twenty-eight patients were studied, 16 underwent unilateral, and the remainder bilateral CND. Twenty-five had PTC, one FTC, one MTC, and one Hashimoto's thyroiditis. Fifteen underwent radioiodine ablation. There were no recurrences with mean follow-up of ten months (range 4-35). Eleven patients (42%) had positive central lymph nodes for metastases. No permanent hypocalcemia resulted, though three (10.7%) patients experienced transient hypocalcemia on POD1 (Ca less than eight). No permanent hypoparathyroidism resulted, though seven (25%) patients had transient hypoparathyroidism (PACU PTH less than eight) treated with shortterm supplementation. No permanent vocal cord paralysis occurred, however transient recurrent laryngeal nerve paresis requiring no intervention occurred in one (3.6%) patient. Excluding patients with positive thyroglobulin antibodies, five had elevated thyroglobulin at one month, and each of these values decreased six months later. At most recent check, 86% of patients had low/undetectable (less than one) thyroglobulin. CONCLUSION: Elective central neck dissection performed with thyroidectomy via a MIVA approach is a safe and effective procedure in our institutional experience. Prospective studies comparing the open and video-assisted approaches need to be performed to make definitive recommendations.
Minimally Invasive Video-Assisted Thyroid Surgery Pain Trial
James O'Neill, MB, MRCSI, MMSc, MD, MBA (presenter)
OBJECTIVE:
The analysis of this prospective study was to compare pain score results in patients who underwent minimally invasive video-assisted (MIVAT) versus minimally invasive open thyroidectomy (MIT) and in doing so further extrapolate and understand the potential advantages of videoassisted thyroid surgery. METHOD: A total of 98 patients post-minimally invasive thyroidectomy from January 1 to December 31, 2008, are the subject matter of this study. Pain scores (0-10) assigned by the patients shortly after the thyroidectomy and after 24 hours post-operative forms the basic outcome variable. For statistical
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